Hasil Pencarian - Feier Feng

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    Hepatocyte growth factor gene-modified adipose-derived mesenchymal stem cells ameliorate radiation induced liver damage in a rat model.

    Hepatocyte growth factor gene-modified adipose-derived mesenchymal stem cells ameliorate radiation induced liver damage in a rat model. oleh Jiamin Zhang, Shiyuan Zhou, Yi Zhou, Feier Feng, Qianming Wang, Xiaolu Zhu, Huisheng Ai, Xiaojun Huang, Xiaohui Zhang

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Adipose-Derived Mesenchymal Stem Cells (ADSCs) with the Potential to Ameliorate Platelet Recovery, Enhance Megakaryopoiesis, and Inhibit Apoptosis of Bone Marrow Cells in a Mouse Model of Radiation-Induced Thrombocytopenia

    Adipose-Derived Mesenchymal Stem Cells (ADSCs) with the Potential to Ameliorate Platelet Recovery, Enhance Megakaryopoiesis, and Inhibit Apoptosis of Bone Marrow Cells in a Mouse M... oleh Jiamin Zhang, Shiyuan Zhou, Yi Zhou, Feier Feng, Qianming Wang, Xiaolu Zhu, Jingzhong Zhao, Haixia Fu, Meng Lv, Huisheng Ai, Xiaojun Huang, Xiaohui Zhang

    Diterbitkan 2016-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in China

    Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in China oleh Jiaxin Liu, Yunfei Hu, Linjun Zhao, Reyizha Nuersulitan, Yanfei Liu, Hui Yu, Yingying Ye, Dedao Wang, Yongjing Tang, Feier Feng, Weiping Liu, Jun Zhu, Lingyan Ping, Yuqin Song

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial

    Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial oleh Yanfei Liu, Lingyan Ping, Yuqin Song, Yongjing Tang, Wen Zheng, Weiping Liu, Zhitao Ying, Chen Zhang, Meng Wu, Feier Feng, Ningjing Lin, Meifeng Tu, Jun Zhu, Yan Xie

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades

    Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades oleh Weiping Liu, Xinqiang Ji, Yuqin Song, Xiaopei Wang, Wen Zheng, Ningjing Lin, Meifeng Tu, Yan Xie, Lingyan Ping, Zhitao Ying, Chen Zhang, Lijuan Deng, Meng Wu, Feier Feng, Xin Leng, Yingli Sun, Tingting Du, Jun Zhu

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies

    Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies oleh Zhitao Ying, Ting He, Xiaopei Wang, Wen Zheng, Ningjing Lin, Meifeng Tu, Yan Xie, Lingyan Ping, Chen Zhang, Weiping Liu, Lijuan Deng, Meng Wu, Feier Feng, Xin Leng, Tingting Du, Feifei Qi, Xuelian Hu, Yanping Ding, Xin-an Lu, Yuqin Song, Jun Zhu

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: